Abstract
Complement is necessary for defense against lung infection with Pseudomonas aeruginosa in mice. We studied in vitro interactions between complement and P. aeruginosa and in vivo effects of complement depletion to better understand this relationship. In vitro, P. aeruginosa strain UI-18 was resistant to killing by mouse serum. However, C3 opsonized the organism (via the alternative and mannose binding lectin [MBL] pathways), and C5 convertase activity on the bacterial surface was demonstrated. In vivo, compared with normal mice, complement-deficient mice experienced higher mortality and failed to sterilize their bronchoalveolar space within 24 h of inoculation. These changes did not seem to be a result of decreased inflammation because complement-deficient mice had normal neutrophil recruitment, greater lung myeloperoxidase content, and, by 24 h, a 35-fold higher level of the CXC chemokine KC. Lung static pressure-volume curves were abnormal in infected animals but were significantly more so in complement deficient mice. These data indicate that although P. aeruginosa is resistant to serum killing, C3 opsonization and C5 convertase assembly occur on its surface. This interaction in vivo plays a central role in host survival beyond just recruitment and activation of phagocytes and may serve to limit the inflammatory response to and tissue injury resulting from bacterial infection.
MeSH Terms
Animals
Chemokine CXCL1
Chemokines/immunology
Chemokines, CXC
Chemotactic Factors/immunology
Chemotaxis, Leukocyte/immunology
Complement C3/immunology,metabolism
Complement C3-C5 Convertases/immunology,metabolism
Complement System Proteins/deficiency
Disease Models, Animal
Female
Host-Parasite Interactions/immunology
Intercellular Signaling Peptides and Proteins/immunology
Mice
Mice, Inbred C57BL
Mice, Knockout
Mortality
Peroxidase/immunology
Pneumonia/immunology,metabolism
Pneumonia, Bacterial/immunology,physiopathology
Pseudomonas Infections/immunology,physiopathology
Pseudomonas aeruginosa/immunology
Pulmonary Alveoli/immunology,microbiology
Respiratory Physiological Phenomena
Chemicals
Chemokine CXCL1
Chemokines
Chemokines, CXC
Chemotactic Factors
Complement C3
Cxcl1 protein, mouse
Intercellular Signaling Peptides and Proteins
Complement System Proteins
Peroxidase
Complement C3-C5 Convertases
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Younger John G
Department of emergency Medicine, Division of Pulmonary and Critical Care Medicine, Univeristy of Michigan, Ann Arbor, MI 48109-0303.
[email protected]
Shankar-Sinha Sunita
Mickiewicz Marc
Brinkman Adam S
Valencia Gabriel A
Sarma J Vidya
Younkin Ellen M
Standiford Theodore J
Zetoune Firas S
Ward Peter A
References (19)
19 references, click to expand
-
Complement receptor 1/CD35 is a receptor for mannan-binding lectin.
J Exp Med. 2000 Dec 18;192(12):1797-808
PMID: 11120776
-
Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
Circulation. 1999 Dec 21-28;100(25):2499-506
PMID: 10604887
-
Complement-mediated host defense in the lung.
Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L790-8
PMID: 11053012
-
Partial liquid ventilation protects lung during resuscitation from shock.
J Appl Physiol (1985). 1997 Nov;83(5):1666-70
PMID: 9375337
-
Protective effects of C5a blockade in sepsis.
Nat Med. 1999 Jul;5(7):788-92
PMID: 10395324
-
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis.
J Clin Invest. 1999 Aug;104(4):431-7
PMID: 10449435
-
The effect of complement depletion on lung clearance of bacteria.
J Clin Invest. 1978 Aug;62(2):373-8
PMID: 27534
-
Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.
J Clin Invest. 1990 Jul;86(1):300-8
PMID: 2164045
-
CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia.
Infect Immun. 2000 Jul;68(7):4289-96
PMID: 10858247
-
Systemic and lung physiological changes in rats after intravascular activation of complement.
J Appl Physiol (1985). 2001 Jun;90(6):2289-95
PMID: 11356794
-
Generation of C5a by phagocytic cells.
Am J Pathol. 2002 Nov;161(5):1849-59
PMID: 12414531
-
Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.
Infect Immun. 1986 Jun;52(3):853-7
PMID: 3086235
-
The C5a chemoattractant receptor mediates mucosal defence to infection.
Nature. 1996 Sep 5;383(6595):86-9
PMID: 8779720
-
Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.
Infect Immun. 1986 Dec;54(3):689-94
PMID: 3096887
-
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.
Crit Care Med. 1999 May;27(5):887-92
PMID: 10362409
-
Roles of the complement receptor type 1 (CR1) and type 3 (CR3) on phagocytosis and subsequent phagosome-lysosome fusion in Salmonella-infected murine macrophages.
FEMS Microbiol Immunol. 1990 Sep;2(2):89-96
PMID: 2147856
-
Detrimental effects of complement activation in hemorrhagic shock.
J Appl Physiol (1985). 2001 Feb;90(2):441-6
PMID: 11160040
-
Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
J Exp Med. 1985 Jun 1;161(6):1414-31
PMID: 2409200
-
Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
J Immunol. 1991 Sep 15;147(6):1983-94
PMID: 1679838